2000 patients join hunt for early warning signs of kidney failure

NCT ID NCT02954419

Recruiting now Knowledge-focused Sponsor: Sun Yat-sen University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 2000 Chinese patients with IgA nephropathy who still have relatively good kidney function. Researchers will test their blood and urine for biomarkers that might predict if and when their kidney disease gets worse. No new treatment is being tested; the goal is to better understand the disease and improve future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors predict which IgA nephropathy patients are at higher risk of kidney failure, enabling earlier and more personalized care.
What could go wrong: This is an observational study, not a treatment trial. It may not identify reliable biomarkers, and results may not apply to non-Chinese populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLOMERULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glomerular disorder IgA glomerulonephritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLOMERULAR DISEASES IGA NEPHROPATHY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

The First Affiliated Hospital,Sun Yat-sen University
RECRUITING

Guangzhou, Guangdong, 510080, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.